ABIVAX SA-ADR

ABVXNASDAQ

🏆 #723 by market capEarnings Sep 21US Equity

$126.81▼ $0.68 (−0.54%)

🌅 Pre-market$127.66▲ 0.67%Regular close · extended-hours price shown

1h—

24h▼ 0.5%

7d▲ 1.2%

14d▲ 6.9%

30d▼ 6.8%

1y▲ 76.2%

🏦Market Cap

$11.06B

Mid Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

45

Weak

Earnings

Q2 · 2026Reported 2026-05-22

Earnings Per Share

Actual

-0.71

Expected

-1.07

beat

+33.60%

YoY +26.80%

Revenue

Actual

$1.51M

Expected

$401.13K

beat

+277.30%

YoY +30.40%

Consensus estimates

Recent quarters

Q2 2026

-0.71

beat

Q1 2026

-1.19

beat

Q4 2025

-2.47

miss

Q3 2025

-0.86

beat